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Feature Section: Pulmonary Issues

Anticoagulant Therapy, Antithrombotic Therapy, Pulmonary
Embolism, and the Henry Ford Hospital Perspective

n this section of the Journal. Leeper and associates describe
the recentfive-yearexperience at Henry Ford Hospital in the
treatment of pulmonary embolism, and 1 review the most recent
literature and consensus opinions regarding the use of anticoagulant and antithrombotic therapy in deep venous thrombosis and pulmonary embolism. These reports are only the most
recent observations resulting from our institution's long and
continuing interest in deep venous thrombosis and pulmonary
embolism. Some of the earliest investigations of the use of anticoagulants in deep venous thrombosis and pulmonary embolism
were carried out at Henry Ford Hospital, In 1940, Dr. Conrad R.
Lam and Dr. R.D. McClure described their experience with
heparin administration, and in 1943 Dr. Lam described his experience with oral anticoagulants. These investigations, and other
early work, are reviewed in my article, "Anticoagulant and
Antithrombotic Therapy in Deep Venous Thrombosis and Pulmonary Embolism," which appears in this section.
Recent interest in pulmonary embolism at our institution has
been sparked by participation in a national collaborative study,
the Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED). Many close and important interdepartmental
collaborations have resulted from this study. Investigators include Drs. John J. Popovich, Jr, James H. Thrall, P.C. Shetty,
Matthew W. Burke, Jerry W. Froelich, Kenneth V. Leeper, Jr,
Barry Lesser, David A. Parker, and Rajinder Sharma. These investigators explored the use of low-dose streptokinase injected
directiy into the pulmonary artery of patients with acute pulmonary embolism (1). These physicians also made important
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contributions to the evaluation of recombinant tissue activated
plasminogen (rt-PA) in the treatment of pulmonary embolism;
this manuscript is currently being prepared by the PIOPED collaborative group. Additional prospective studies of the use of
rt-PA in pulmonary embolism are underway. New treatments
and diagnostic modalities in pulmonary embolism continue
to be explored at Henry Ford Hospital. One possible, exciting
direction concerns mechanical techniques for fragmenting
pulmonary emboli with catheter-tip devices.
Paul D. Stein, MD
(Principal Investigator, PIOPED Study)
Heart and Vascular Institute
Cardiovascular Research
Henry Ford Hospital

Reference
I. Leeper KV Jr, Popovich JP Jr, Lesser B A, et al. Treatment of massive acute
pulmonary embolism with low doses of intrapulmonary arterial streptokinase
combined with full doses of systemic heparin. Chest 1988:93:234-40.

In addition lo these papers concerning pulmonary embolism and
anticoagulant therapy, this section on pulmonary issues includes an unusual case report of long-standing disseminated Strongyloides stercoralis presenting as diffuse interstitial pneumonitis as well as the
imaginative attempt by Dr Benish and colleagues to construct a mathematical expression of lung
elasticity.—Editor

Editorial—Stein

